Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 4


The use of routine monitoring of donor-derived cell-free DNA (dd-cfDNA) after kidney transplant may allow clinicians to identify subclinical allograft injury and intervene prior

  • 1542929977318019072 Profile photo of Madelyn

    2. What did I miss? AKI in txp can be challenging to diagnose w/o a biopsy. Donor-derived cell-free DNA (dd-cfDNA) is regularly released from injured graft cells, but levels rise after injury & apoptosis. ADMIRAL sought to report more data on this marker https://t.co/kABbMBqxZF - view on twitter